MD Anderson

Madrid 28033

1 studies enrolling now · 2 studies all time

What they study most

1st Line NSCLC, Advanced Solid Tumor, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Non Small Cell Lung Cancer, Primary Peritoneal Cancer, Untreated Advanced NSCLC

Studies at this site

• Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers — Recruiting now
• Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer — Completed